UMKC doctor claims new formula beats blood in treating severe shock

A doctor at the University of Missouri-Kansas City has proposed a new treatment for severe blood loss that he argues outperforms standard blood transfusions. The researcher, who also holds a position as a research scientist at the university, describes the experimental therapy as "better than blood."

The protocol relies on a combination of ingredients commonly found in grocery stores. The doctor stated that these specific components work together to address the physiological crisis known as hemorrhagic shock. This condition occurs when a person loses a large volume of blood rapidly, often due to trauma from events like car crashes or gunshot wounds.

Currently, the medical community relies on blood transfusions as the primary method for stabilizing patients with severe hemorrhaging. However, the availability of donated blood remains a persistent logistical challenge for hospitals. The new approach aims to provide an immediate intervention for patients who may not have access to a transfusion in the critical early minutes of an injury.

Some members of the medical community have expressed hope that this discovery could alleviate the strain on regional blood supply chains. By offering a viable alternative for initial stabilization, the treatment could reduce the volume of blood required for each patient. This shift could help manage the constant demand from trauma centers that serve high-volume accident cases.

The research is part of a broader effort to find faster, more accessible solutions for emergency care. While the doctor emphasizes the efficacy of the new mixture, the treatment is currently in the testing phase. The goal is to validate the results in a clinical setting before expanding its use to other institutions.

The development follows a pattern of innovation in emergency medicine where off-the-shelf ingredients are being repurposed for critical care. The researcher is working to determine the precise ratios of the ingredients needed for the most effective response to severe trauma.

The university plans to continue studying the long-term effects of the treatment. The next steps involve gathering data on patient recovery rates when this formula is used alongside or instead of traditional transfusions.